Literature DB >> 12724732

Cancer and ageing: rival demons?

Judith Campisi1.   

Abstract

Organisms with renewable tissues use a network of genetic pathways and cellular responses to prevent cancer. The main mammalian tumour-suppressor pathways evolved from ancient mechanisms that, in simple post-mitotic organisms, act predominantly to regulate embryogenesis or to protect the germline. The shift from developmental and/or germline maintenance in simple organisms to somatic maintenance in complex organisms might have evolved at a cost. Recent evidence indicates that some mammalian tumour-suppressor mechanisms contribute to ageing. How might this have happened, and what are its implications for our ability to control cancer and ageing?

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12724732     DOI: 10.1038/nrc1073

Source DB:  PubMed          Journal:  Nat Rev Cancer        ISSN: 1474-175X            Impact factor:   60.716


  139 in total

Review 1.  Using mice to examine p53 functions in cancer, aging, and longevity.

Authors:  Lawrence A Donehower
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-11-04       Impact factor: 10.005

2.  An age-period-cohort analysis of cancer incidence among the oldest old, Utah 1973-2002.

Authors:  Heidi A Hanson; Ken R Smith; Antoinette M Stroup; C Janna Harrell
Journal:  Popul Stud (Camb)       Date:  2014-11-14

3.  Glucocorticoids suppress selected components of the senescence-associated secretory phenotype.

Authors:  Remi-Martin Laberge; Lili Zhou; Melissa R Sarantos; Francis Rodier; Adam Freund; Peter L J de Keizer; Su Liu; Marco Demaria; Yu-Sheng Cong; Pankaj Kapahi; Pierre-Yves Desprez; Robert E Hughes; Judith Campisi
Journal:  Aging Cell       Date:  2012-04-17       Impact factor: 9.304

4.  A molecular signature predictive of indolent prostate cancer.

Authors:  Shazia Irshad; Mukesh Bansal; Mireia Castillo-Martin; Tian Zheng; Alvaro Aytes; Sven Wenske; Clémentine Le Magnen; Paolo Guarnieri; Pavel Sumazin; Mitchell C Benson; Michael M Shen; Andrea Califano; Cory Abate-Shen
Journal:  Sci Transl Med       Date:  2013-09-11       Impact factor: 17.956

5.  Shortened telomeres in circulating leukocytes of patients with chronic obstructive pulmonary disease.

Authors:  Laurent Savale; Ari Chaouat; Sylvie Bastuji-Garin; Elisabeth Marcos; Laurent Boyer; Bernard Maitre; Mourad Sarni; Bruno Housset; Emmanuel Weitzenblum; Mireille Matrat; Philippe Le Corvoisier; Dominique Rideau; Jorge Boczkowski; Jean-Luc Dubois-Randé; Christos Chouaid; Serge Adnot
Journal:  Am J Respir Crit Care Med       Date:  2009-01-29       Impact factor: 21.405

6.  Oxidative Stress Increases the Number of Stress Granules in Senescent Cells and Triggers a Rapid Decrease in p21waf1/cip1 Translation.

Authors:  Xian Jin Lian; Imed-Eddine Gallouzi
Journal:  J Biol Chem       Date:  2009-01-28       Impact factor: 5.157

7.  Telomere loss, senescence, and genetic instability in CD4+ T lymphocytes overexpressing hTERT.

Authors:  Alexander Röth; Gabriela M Baerlocher; Mike Schertzer; Elizabeth Chavez; Ulrich Dührsen; Peter M Lansdorp
Journal:  Blood       Date:  2005-03-01       Impact factor: 22.113

8.  An essential role for senescent cells in optimal wound healing through secretion of PDGF-AA.

Authors:  Marco Demaria; Naoko Ohtani; Sameh A Youssef; Francis Rodier; Wendy Toussaint; James R Mitchell; Remi-Martin Laberge; Jan Vijg; Harry Van Steeg; Martijn E T Dollé; Jan H J Hoeijmakers; Alain de Bruin; Eiji Hara; Judith Campisi
Journal:  Dev Cell       Date:  2014-12-11       Impact factor: 12.270

9.  Trade-off between cancer and aging: what role do other diseases play? Evidence from experimental and human population studies.

Authors:  Anatoli I Yashin; Svetlana V Ukraintseva; Igor V Akushevich; Konstantin G Arbeev; Alexander Kulminski; Lucy Akushevich
Journal:  Mech Ageing Dev       Date:  2008-03-25       Impact factor: 5.432

Review 10.  p53--a Jack of all trades but master of none.

Authors:  Melissa R Junttila; Gerard I Evan
Journal:  Nat Rev Cancer       Date:  2009-09-24       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.